Advanced epithelial ovarian cancer, cancer of the fallopian tube and primary peritoneal cancer have a poor prognosis and a high rate of disease recurrence following primary therapy. Recurrent ...
“Several clinical trials have confirmed the role of hormone therapy in recurrent ovarian cancer treatment, especially in patients with low-grade tumors,” says review author Dr. Siqing ...
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...
Future Oncol. 2012;8(9):1135-1147. Follow-up, initiation, execution and tailoring of treatment in case of recurrence of ovarian cancer have to take into account evidence-based guidelines and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback